{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:58:43Z","timestamp":1784696323934,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020192","name":"Medtronic Europe","doi-asserted-by":"publisher","award":["Medtronic Europe"],"award-info":[{"award-number":["Medtronic Europe"]}],"id":[{"id":"10.13039\/100020192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10198-024-01739-2","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T07:00:54Z","timestamp":1732345254000},"page":"745-755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cost-effectiveness of TAVI in the United Kingdom: a long-term analysis based on 4-year data from the Evolut Low Risk Trial"],"prefix":"10.1007","volume":"26","author":[{"given":"Daniel J.","family":"Blackman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Ryschon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail M.","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5078-1939","authenticated-orcid":false,"given":"Jan B.","family":"Pietzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"key":"1739_CR1","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/CIRCULATIONAHA.113.003961","volume":"129","author":"AS Go","year":"2014","unstructured":"Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., et al.: Heart disease and stroke statistics\u20142014 update: A report from the American Heart Association. Circulation. 129, e28\u2013e292 (2014)","journal-title":"Circulation"},{"key":"1739_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., et al.: 2021 ESC\/EACTS guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-thoracic surgery (EACTS). Eur. Heart J. 43, 561\u2013632 (2022)","journal-title":"Eur. Heart J."},{"key":"1739_CR3","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.jacc.2016.02.057","volume":"67","author":"P G\u00e9n\u00e9reux","year":"2016","unstructured":"G\u00e9n\u00e9reux, P., Stone, G.W., O\u2019Gara, P.T., Marquis-Gravel, G., Redfors, B., Giustino, G., et al.: Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J. Am. Coll. Cardiol. 67, 2263\u20132288 (2016)","journal-title":"J. Am. Coll. Cardiol."},{"key":"1739_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1161\/01.CIR.66.5.1105","volume":"66","author":"F Schwarz","year":"1982","unstructured":"Schwarz, F., Baumann, P., Manthey, J., Hoffmann, M., Schuler, G., Mehmel, H.C., et al.: The effect of aortic valve replacement on survival. Circulation. 66, 1105\u20131110 (1982)","journal-title":"Circulation"},{"key":"1739_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.14740\/cr966","volume":"10","author":"AA Khan","year":"2019","unstructured":"Khan, A.A., Murtaza, G., Khalid, M.F., Khattak, F.: Risk stratification for transcatheter aortic valve replacement. Cardiol. Res. 10, 323 (2019)","journal-title":"Cardiol. Res."},{"key":"1739_CR6","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, S.M., Feng, L., He, X., Xian, Y., Jacobs, J.P., Badhwar, V., et al.: The Society of thoracic surgeons 2018 adult cardiac surgery risk models: Part 2\u2014statistical methods and results. (2018). The Annals of thoracic surgery.105,1419-28","DOI":"10.1016\/j.athoracsur.2018.03.003"},{"key":"1739_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.athoracsur.2023.11.016","volume":"117","author":"MCW von Ballmoos","year":"2024","unstructured":"von Ballmoos, M.C.W., Kaneko, T., Iribarne, A., Kim, K.M., Arghami, A., Fiedler, A., et al.: The society of thoracic surgeons adult cardiac surgery database: 2023 update on procedure data and research. Ann. Thorac. Surg. 117, 260\u2013270 (2024)","journal-title":"Ann. Thorac. Surg."},{"key":"1739_CR8","doi-asserted-by":"crossref","unstructured":"Wienemann, H., Maier, O., Beyer, M., Portratz, M., Tanaka, T., Mauri, V., et al.: Cusp overlap versus standard three-cusp technique for self-expanding Evolut transcatheter aortic valves. (2023). EuroIntervention.19,e176","DOI":"10.4244\/EIJ-D-22-01030"},{"key":"1739_CR9","doi-asserted-by":"crossref","unstructured":"Spears, J., Al-Saiegh, Y., Goldberg, D., Manthey, S., Goldberg, S.: TAVR: A review of current practices and considerations in low-risk patients. J. Interventional Cardiol. 2020,2582938 (2020)","DOI":"10.1155\/2020\/2582938"},{"key":"1739_CR10","doi-asserted-by":"crossref","unstructured":"Kawsara, A., Sulaiman, S., Linderbaum, J., Coffey, S.R., Alqahtani, F., Nkomo, V.T., Temporal trends in resource use, et al. (eds.): cost, and outcomes of transcatheter aortic valve replacement in the United States. Mayo Clinic Proceedings: Elsevier. (2020)","DOI":"10.1016\/j.mayocp.2020.05.043"},{"key":"1739_CR11","first-page":"373","volume":"16","author":"AK Okoh","year":"2021","unstructured":"Okoh, A.K., Siddiqui, E., Soto, C., Dhaduk, N., Hirji, S., Tayal, R., et al.: Trends in early discharge and associated costs after transcatheter aortic valve replacement: A national perspective. Innovations. 16, 373\u2013378 (2021)","journal-title":"Innovations"},{"key":"1739_CR12","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1093\/eurheartj\/ehaa475","volume":"41","author":"E Barbato","year":"2020","unstructured":"Barbato, E., Noc, M., Baumbach, A., Dudek, D., Bunc, M., Skalidis, E., et al.: Mapping interventional cardiology in Europe: The European Association of Percutaneous Cardiovascular Interventions (EAPCI) atlas project. Eur. Heart J. 41, 2579\u20132588 (2020)","journal-title":"Eur. Heart J."},{"key":"1739_CR13","doi-asserted-by":"crossref","unstructured":"Ali, N., Faour, A., Rawlins, J., Dawkins, S., Appleby, C.E., MacCarthy, P., et al.: \u2018Valve for life\u2019: Tackling the deficit in transcatheter treatment of heart valve disease in the UK. Open. Heart 8, (2021)","DOI":"10.1136\/openhrt-2020-001547"},{"key":"1739_CR14","unstructured":"NHS.: Transcatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR) for symptomatic, severe aortic stenosis (adults) to support elective performance: NHS England position statement. (2023). https:\/\/www.england.nhs.uk\/long-read\/tavi-and-savr-position-statement\/ Accessed 12 February 2024"},{"key":"1739_CR15","unstructured":"NHS England: Delivering plan for tackling the COVID-19 backlog of elective care. (2022). https:\/\/www.england.nhs.uk\/coronavirus\/delivering-plan-for-tackling-the-covid-19-backlog-of-elective-care\/ Accessed 12 February 2024"},{"key":"1739_CR16","doi-asserted-by":"crossref","unstructured":"Gilard, M., Eltchaninoff, H., Iung, B., Lef\u00e8vre, T., Spaulding, C., Dumonteil, N., et al.: Cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation procedure compared with surgery in patients with severe aortic stenosis at low risk of surgical mortality in France. (2022). Value in Health.25,605\u2009\u2013\u200913","DOI":"10.1016\/j.jval.2021.10.003"},{"key":"1739_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s12325-022-02392-y","volume":"40","author":"KH Kuck","year":"2023","unstructured":"Kuck, K.H., Leidl, R., Frankenstein, L., Wahlers, T., Sarmah, A., Candolfi, P., et al.: Cost-effectiveness of SAPIEN 3 transcatheter aortic valve implantation Versus Surgical aortic valve replacement in German severe aortic stenosis patients at Low Surgical Mortality Risk. Adv. Therapy. 40, 1031\u20131046 (2023)","journal-title":"Adv. Therapy"},{"key":"1739_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijcard.2022.03.034","volume":"357","author":"FS Mennini","year":"2022","unstructured":"Mennini, F.S., Meucci, F., Pesarini, G., Vandoni, P., Lettino, M., Sarmah, A., et al.: Cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in low surgical risk aortic stenosis patients. Int. J. Cardiol. 357, 26\u201332 (2022)","journal-title":"Int. J. Cardiol."},{"key":"1739_CR19","unstructured":"NICE.: Heart valve disease presenting in adults: investigation and management, Cost-utility analysis: Transcatheter intervention for patients who have operable aortic stenosis NICE guideline NG208. (2021). https:\/\/www.nice.org.uk\/guidance\/ng208\/evidence\/tavi-economic-analysis-pdf-10890776557 Accessed 12 February 2024"},{"key":"1739_CR20","doi-asserted-by":"crossref","unstructured":"Tch\u00e9tch\u00e9, D., de Gennes, C.D., Cormerais, Q., Geisler, B.P., Dutot, C., Wilquin-Bequet, F., et al.: Cost-effectiveness of transcatheter aortic valve implantation in patients at low surgical risk in France: A model-based analysis of the evolut LR trial. Eur. J. Health Econ.1\u201311 (2023)","DOI":"10.1007\/s10198-023-01590-x"},{"key":"1739_CR21","doi-asserted-by":"crossref","unstructured":"Dubois, C., Adriaenssens, T., Annemans, L., Bosmans, J., Callebaut, B., Candolfi, P., et al.: Transcatheter aortic valve implantation versus surgical aortic valve replacement in severe aortic stenosis patients at low surgical mortality risk: A cost-effectiveness analysis in Belgium. Acta Cardiol.1\u201312 (2023)","DOI":"10.1080\/00015385.2023.2282283"},{"key":"1739_CR22","unstructured":"Health Information & quality Authority (HIQA): Health Technology Assessment of transcatheter aortic valve implantation (TAVI) in patients with severe symptomatic aortic stenosis at low and intermediate risk of surgical complications. (2019). https:\/\/www.hiqa.ie\/sites\/default\/files\/2019-12\/TAVI_HTA.pdf Accessed 13 February 2024"},{"key":"1739_CR23","unstructured":"Norwegian Institute of Public Health (NIPH): Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups: a health technology assessment. (2021). https:\/\/www.fhi.no\/en\/publ\/2021\/TAVI-vs-SAVR-for-patients-with-severe-aortic-stenosis-and-low-surgical-risk-and-across-surgical-risk-groups\/ Accessed 12 February 2024"},{"key":"1739_CR24","doi-asserted-by":"publisher","unstructured":"Geisler, B.P., Huygens, S.A., Reardon, M.J., Van Mieghem, N., Kappetein, A.P., Osnabrugge, R.L.J., et al.: Cost-effectiveness and projected survival of self-expanding transcatheter Versus Surgical aortic valve replacement for high risk patients in a European setting: A Dutch analysis based on the CoreValve High Risk Trial. Struct. Heart. 1(267\u201374) (2017). https:\/\/doi.org\/10.1080\/24748706.2017.1381357","DOI":"10.1080\/24748706.2017.1381357"},{"key":"1739_CR25","doi-asserted-by":"crossref","unstructured":"Geisler, B.P., J\u00f8rgensen, T.H., Thyregod, H.G.H., Pietzsch, J.B., S\u00f8ndergaard, L.: Cost-effectiveness of Transcatheter versus Surgical aortic valve replacement in patients at lower surgical risk: Results from the NOTION trial. EIJ-D-18-00847; (2019)","DOI":"10.4244\/EIJ-D-18-00847"},{"key":"1739_CR26","unstructured":"National Institute for Health Care Excellence: The Guidelines Manual. National Institute for Health and Care Excellence (2012)"},{"key":"1739_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1747-4949.2008.00188.x","volume":"3","author":"D Leys","year":"2008","unstructured":"Leys, D., B\u00e9jot, Y., Debette, S., Giroud, M.: Burden of stroke in France. Int. J. Stroke. 3, 117\u2013119 (2008)","journal-title":"Int. J. Stroke"},{"key":"1739_CR28","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.jacc.2023.09.813","volume":"82","author":"JK Forrest","year":"2023","unstructured":"Forrest, J.K., Deeb, G.M., Yakubov, S.J., Gada, H., Mumtaz, M.A., Ramlawi, B., et al.: 4-Year outcomes of patients with aortic stenosis in the evolut low risk trial. J. Am. Coll. Cardiol. 82, 2163\u20132165 (2023)","journal-title":"J. Am. Coll. Cardiol."},{"key":"1739_CR29","unstructured":"Office for National Statistics (ONS): National life tables: UK: Office for National Statistics (ONS). (2021). https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/lifeexpectancies\/datasets\/nationallifetablesunitedkingdomreferencetables Accessed 15 February 2024"},{"key":"1739_CR30","unstructured":"NHS England: \/22 National Cost Collection Data Publication. (2021). https:\/\/www.england.nhs.uk\/publication\/2021-22-national-cost-collection-data-publication\/ (2023). Accessed 13 February 2024"},{"key":"1739_CR31","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1001\/jama.2022.5776","volume":"327","author":"The UK TAVI Trial Investigators","year":"2022","unstructured":"The UK TAVI Trial Investigators: Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: A randomized clinical trial. JAMA. 327, 1875\u20131887 (2022). https:\/\/doi.org\/10.1001\/jama.2022.5776","journal-title":"JAMA"},{"key":"1739_CR32","unstructured":"NHS Benchmarking Network Intermediate Care Summary Report: (2021). https:\/\/www.csp.org.uk\/system\/files\/documents\/2022-01\/nhsbn_intermediate_care_summary_report_2021.pdf (2021). Accessed 13 February 2024"},{"key":"1739_CR33","doi-asserted-by":"crossref","unstructured":"Mack, M.J., Leon, M.B., Thourani, V.H., Makkar, R., Kodali, S.K., Russo, M., et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N. Engl. J. Med. (2019), 380, 1695\u2009\u2013\u2009705","DOI":"10.1056\/NEJMoa1814052"},{"key":"1739_CR34","unstructured":"von Petersdorff, C., Patrignani, P., Landzaat, W., Jones, S.: Modelling demand and costs for palliative care services in England A final report for Sue Ryder. (2021). https:\/\/www.sueryder.org\/sites\/default\/files\/2021-03\/Modelling_Demand_and_Costs_for_Palliative_Care_Services_in_England%20%281%29.pdf Accessed 13 February 2024"},{"key":"1739_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/2396987317746516","volume":"3","author":"X-M Xu","year":"2018","unstructured":"Xu, X.-M., Vestesson, E., Paley, L., Desikan, A., Wonderling, D., Hoffman, A., et al.: The economic burden of stroke care in England, Wales and Northern Ireland: Using a national stroke register to estimate and report patient-level health economic outcomes in stroke. Eur. stroke J. 3, 82\u201391 (2018)","journal-title":"Eur. stroke J."},{"key":"1739_CR36","doi-asserted-by":"publisher","unstructured":"Jones, K.C., Weatherly, H., Birch, S., Castelli, A., Chalkley, M., Dargan, A., et al.: Unit costs of health and social care 2023 manual. Technical report. Personal Social Services Research Unit (University of Kent) & Centre for Health Economics (University of York), Kent, UK, (2024). https:\/\/doi.org\/10.22024\/UniKent%2F01.02.105685","DOI":"10.22024\/UniKent%2F01.02.105685"},{"key":"1739_CR37","doi-asserted-by":"crossref","unstructured":"Hatswell, A., Bullement, A., Paulden, M., Stevenson, M.: Probabilistic sensitivity analysis in health economic models; how many simulations should we run? Value Health 20 A746 (2017)","DOI":"10.1016\/j.jval.2017.08.2074"},{"key":"1739_CR38","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/eurheartj\/ehae043","volume":"45","author":"HGH Thyregod","year":"2024","unstructured":"Thyregod, H.G.H., J\u00f8rgensen, T.H., Ihlemann, N., Steinbr\u00fcchel, D.A., Nissen, H., Kjeldsen, B.J., et al.: Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur. Heart J. 45, 1116\u20131124 (2024). https:\/\/doi.org\/10.1093\/eurheartj\/ehae043","journal-title":"Eur. Heart J."},{"key":"1739_CR39","unstructured":"Office for National Statistics (ONS): Life Expectancy Calculator. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/healthandlifeexpectancies\/articles\/lifeexpectancycalculator\/2019-06-07 Accessed 16 April 2024"},{"key":"1739_CR40","unstructured":"Getting it Right First Time: Optimising the Transcatheter Aortic Valve Implantation Pathway. (2023). https:\/\/gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2023\/02\/Delivery-guide_Optimising-the-TAVI-pathway-South-Tees-Hospitals-NHSFT-February-2023-FINAL-V1.pdf Accessed 12 February 2024"},{"key":"1739_CR41","doi-asserted-by":"crossref","unstructured":"Padaliya, B., Pathak, S., Riley, R., Ashton, K.: TCT-476 same-day discharge after Minimalist, Self-Expanding transcatheter aortic valve replacement in a Community Hospital during the COVID-19 pandemic. (2021). Journal of the American College of Cardiology.78,B195-B6","DOI":"10.1016\/j.jacc.2021.09.1329"},{"key":"1739_CR42","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jcin.2021.12.046","volume":"15","author":"M Barker","year":"2022","unstructured":"Barker, M., Sathananthan, J., Perdoncin, E., Devireddy, C., Keegan, P., Grubb, K., et al.: Same-day discharge post\u2013transcatheter aortic valve replacement during the COVID-19 pandemic: The Multicenter PROTECT TAVR Study. Cardiovasc. Interventions. 15, 590\u2013598 (2022)","journal-title":"Cardiovasc. Interventions"},{"key":"1739_CR43","doi-asserted-by":"publisher","unstructured":"Ludman, P.F., BCIS National Audit Adult Interventional Procedures: April: (1st to 31st March 2022). https:\/\/www.bcis.org.uk\/audit-results\/ (2022). Accessed 13 June 202444. Pascual I, Hern\u00e1ndez-Vaquero D, Alperi A, Almendarez M, Avanzas P, Kalavrouziotis D,: Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR. JACC: Cardiovascular Interventions.15,150\u2009\u2013\u200961 (2022). (2021). https:\/\/doi.org\/10.1016\/j.jcin.2021.10.002","DOI":"10.1016\/j.jcin.2021.10.002"},{"key":"1739_CR44","doi-asserted-by":"crossref","unstructured":"Grubb, K.J., Gada, H., Mittal, S., Nazif, T., Rod\u00e9s-Cabau, J., Fraser, D.G., et al.: Clinical impact of standardized TAVR technique and care pathway: Insights from the Optimize PRO study. (2023). Cardiovascular Interventions.16,558\u2009\u2013\u200970","DOI":"10.1016\/j.jcin.2023.01.016"},{"key":"1739_CR45","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jcin.2024.01.292","volume":"17","author":"KJ Grubb","year":"2024","unstructured":"Grubb, K.J., Lisko, J.C., O\u2019Hair, D., Merhi, W., Forrest, J.K., Mahoney, P., et al.: Reinterventions after CoreValve\/Evolut transcatheter or surgical aortic valve replacement for treatment of severe aortic stenosis. Cardiovasc. Interventions. 17, 1007\u20131016 (2024)","journal-title":"Cardiovasc. Interventions"},{"key":"1739_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/jamacardio.2022.4627","volume":"8","author":"D O\u2019Hair","year":"2023","unstructured":"O\u2019Hair, D., Yakubov, S.J., Grubb, K.J., Oh, J.K., Ito, S., Deeb, G.M., et al.: Structural valve deterioration after self-expanding transcatheter or surgical aortic valve implantation in patients at intermediate or high risk. JAMA Cardiol. 8, 111\u2013119 (2023)","journal-title":"JAMA Cardiol."},{"key":"1739_CR47","unstructured":"NHS England: Hospital Episode Statistics (HES). https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics. Accessed 13 February 2024"},{"key":"1739_CR48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816885","author":"JJ Popma","year":"2019","unstructured":"Popma, J.J., Deeb, G.M., Yakubov, S.J., Mumtaz, M., Gada, H., O\u2019Hair, D., et al.: Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. New. Engl. J. Med. 380. (2019). https:\/\/doi.org\/10.1056\/NEJMoa1816885, 1706-15","journal-title":"New. Engl. J. Med. 380"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-024-01739-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-024-01739-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-024-01739-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T10:18:37Z","timestamp":1751019517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-024-01739-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1739"],"URL":"https:\/\/doi.org\/10.1007\/s10198-024-01739-2","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DJB reports consulting fees from Medtronic Plc. and Abbott Vascular, honoraria from Medtronic Plc., Abbott Vascular, and Edwards Lifesciences, and participation in data safety\/monitoring\/advisory board for Medtronic Plc and Abbott Vascular. AMR, AMG, and JBP are employees of Wing Tech Inc., a health economics consulting firm and core lab that developed the underlying analysis framework and reports consulting fees from Medtronic Plc. SB is an employee of Medtronic Plc. JKF reports grant support\/research contracts and consultant fees\/Honoria\/speakers bureau fees from Edwards Lifesciences and Medtronic Plc. MRR. reports research grants from Abbott, Boston Scientific, WL Gore Medical, and Medtronic Plc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}